直接PCI治疗的STEMI患者造影剂急性肾损伤与死亡率
该前瞻性观察研究纳入1114例接受直接PCI的STEMI患者,比较四种CI-AKI定义对院内死亡、1年死亡或透析需求的预测价值。RIFLE(CKD-EPI)定义最具判别力,其CI-AKI患者院内死亡、1年死亡及1年透析风险均显著升高。
要点
- RIFLE(CKD-EPI)定义对院内死亡、1年死亡和1年透析需求的判别力最优。
- CI-AKI是直接PCI治疗STEMI患者常见且严重的并发症。
- 造影剂用量与肌酐升高或eGFR下降无显著相关性。
核心结论
- CI-AKI是直接PCI治疗STEMI患者常见且严重的并发症。
- RIFLE(CKD-EPI)定义是识别死亡或透析高危CI-AKI患者最准确的定义。
研究设计与样本
- 前瞻性观察性研究,连续纳入1114例接受直接PCI的STEMI患者。
- 采用四种CI-AKI定义(CIN、AKIN、RIFLE-MDRD、RIFLE-CKD-EPI)评估关联。
主要发现
- CI-AKI发生率按CIN、AKIN、RIFLE-MDRD、RIFLE-CKD-EPI定义分别为18.3%、12.2%、15.6%、10.5%。
- RIFLE(CKD-EPI)定义CI-AKI患者院内死亡27.1% vs 4.0%,调整OR 2.7(95%CI 1.4-5.1),p=0.003。
- RIFLE(CKD-EPI)定义CI-AKI患者1年死亡27.4% vs 6.6%,调整OR 2.8(95%CI 1.5-5.3),p=0.002。
- RIFLE(CKD-EPI)定义CI-AKI患者1年透析15.6% vs 2.7%,调整OR 6.7(95%CI 3.3-13.6),p=0.001。
- 血流动力学不稳定、心脏骤停、既存肾衰竭、高龄和高造影剂用量与1年死亡独立相关。
关键数值与推荐
- RIFLE(CKD-EPI)定义下CI-AKI与院内死亡调整OR 2.7(95%CI 1.4-5.1),p=0.003。
- RIFLE(CKD-EPI)定义下CI-AKI与1年死亡调整OR 2.8(95%CI 1.5-5.3),p=0.002。
- RIFLE(CKD-EPI)定义下CI-AKI与1年透析调整OR 6.7(95%CI 3.3-13.6),p=0.001。
临床怎么用
- 采用RIFLE(CKD-EPI)定义识别直接PCI后CI-AKI高危患者。
- 对合并血流动力学不稳定、心脏骤停、既存肾衰竭、高龄或高造影剂用量的患者加强监测。
局限性
- 造影剂用量与肌酐升高(r=0.06)或eGFR下降(r=0.05)无显著相关性,提示单中心观察性研究可能存在混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Contrast-induced acute kidney injury (CI-AKI) is a common and potentially severe complication in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI). There is no consensus on the best definition of CI-AKI to identify patients at risk of haemodialysis or death. The objective of this study was to assess the association of CI-AKI, using four definitions, on inhospital mortality, mortality or haemodialysis requirement over 1-year follow-up, in patients with STEMI treated with pPCI. METHODS: In this prospective, observational study, all patients with STEMI referred for pPCI were included. We identified independent variables associated with CI-AKI and mortality. RESULTS: We included 1114 consecutive patients with STEMI treated by pPCI. CI-AKI occurred in 18.3%, 12.2%, 15.6% and 10.5% of patients according to the CIN, Acute Kidney Injury Network (AKIN), Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE) Modification of Diet in Renal Disease (MDRD) and RIFLE Chronic Kidney Disease - Epidemiology Collaboration (CKD-EPI) definitions, respectively. The RIFLE (CKD-EPI) definition was the most discriminant definition to identify patients at higher risk of inhospital mortality (27.1% vs 4.0%; adjusted OR 2.7 (95% CI 1.4 to 5.1), p=0.003), 1-year mortality (27.4% vs 6.6%; adjusted OR 2.8 (95% CI 1.5 to 5.3), p=0.002) and haemodialysis requirement at 1-year follow-up (15.6% vs 2.7%; adjusted OR 6.7 (95% CI 3.3 to 13.6), p=0.001). Haemodynamic instability, cardiac arrest, preexisting renal failure, elderly age and a high contrast media volume were independently associated with 1-year mortality. Of interest, contrast-media volume was not correlated to increase of creatininaemia (r=0.06) or decrease in estimated glomerular filtration rate (r=0.05) after percutaneous coronary intervention in our population. CONCLUSIONS: CI-AKI is a frequent and serious complication of STEMI treated by pPCI. The RIFLE definition is the most accurate definition to identify patients with CI-AKI at high risk of mortality or haemodialysis.
引用
- Silvain J, Nguyen LS, Spagnoli V, et al. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2017. PMID: 29092921. doi:10.1136/heartjnl-2017-311975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。